Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from US Food and Drug Administration

Scholar Rock's Spinal Muscular Atrophy Drug Faces FDA Delay Over Catalent Indiana Inspection

The U.S. Food and Drug Administration (FDA) on Tuesday issued a Complete Response Letter (CRL) for Scholar Rock’s (NASDAQ:SRRK) apitegromab Biologics License Application (BLA) for spinal muscular atrophy (SMA).

Benzinga

Nationwide fish recall issued after health risk uncovered

The products may have been contaminated with disease-causing bacteria

The Independent UK

FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months

The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.’s (NASDAQ:MRNA) supplemental Biologics License Application (sBLA) for Spikevax, the company’s COVID-19 vaccine, in children six months through 11 years of age who are at increased risk for COVID-19 disease.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA issues highest risk level recall for over 6,000 tubs of protein powder

Controversies around protein powder refuse to stop. A week after findings of a study suggested presence of heavy metals in protein powders, a renowned protein powder brand Orgain has issued a voluntary recall of its chocolate-flavored “30g Plant Protein Complete Protein Powder” due to undeclared peanut allergens. The US Food…

The Times of India

Salmonella outbreak prompts widespread cucumber recall in US and Canada

Brand of cucumbers recalled due to contamination across 26 states and five Canadian provinces

The Independent UK

3 Healthcare Stocks Positioned for Major Gains in 2024

With advancements in biomedical sciences and promising drug pipelines, the healthcare industry is set for substantial growth in the coming years. Hence, investors might find opportunities in adding UnitedHealth Group (UNH), Merck & Co. (MRK), and Pfizer (PFE) to their portfolios for potential gains this year. Read on….

StockNews.com

US seeks freeze on Texas abortion pill ruling, clarity on conflicting order

WASHINGTON — The Biden administration asked a federal appeals court to suspend a ruling by a conservative U.S. judge in Texas that would block access nationwide to a key drug used in medication abortions — even as it sought clarity on a conflicting order in Washington state.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

4 Stocks to Buy in Any Market Climate

The stock market is expected to remain volatile in the near term as investors remain anxious about the Fed’s actions. Amid high recession worries, fundamentally strong healthcare stocks, Pfizer (PFE), Bristol-Myers Squibb (BMY), Amgen (AMGN), and Elevance Health (ELV), which have the potential to withstand any market downturns, could be…

StockNews.com

2 Pharma Stocks to Buy Right Now and 1 You Might Want to Consider Selling

The pharmaceutical industry is evolving with personalized medicines and the rapid adoption of RPM technology, which should boost growth. Moreover, with a recession lurking, fundamentally strong pharma stocks AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) might be ideal buys. However, SNDL (SNDL) might be best avoided. Keep reading to know why.

StockNews.com

The maker of Enfamil recalls 145,000 cans of infant formula over bacteria risks

Reckitt says despite contamination fears, the recalled formula tested negative for Cronobacter, which can cause rare but deadly infections in infants. Here's how to identify and prevent them.

WEKU

3 Stocks You Won't Have Regrets About Buying in 2023

January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…

StockNews.com

The Most Active Stocks to Buy on Wall Street This Week

Amid concerns that an estimate-beating labor market tightness may embolden the Fed to keep pushing interest rates upward, fundamentally strong stocks Pfizer (PFE), Verizon (VZ), and AT&T (T) have deservedly found takers on Wall Street. Read on….

StockNews.com

3 Stocks to Buy if You're Building a Portfolio From Scratch

Shares of Pfizer (PFE), Centene (CNC), and Kellogg (K) could provide a solid foundation to new portfolios for sustained wealth creation, given the fundamental strength, consistent profitability, and resilient demand of these companies. Continue reading….

StockNews.com

Pro-abortion rights advocates sue over state pill restrictions

The lawsuit comes as Republican-led states in the US attempt to crack down on the use of abortion-inducing medications.

Al Jazeera

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India

Coronavirus: US proposes annual COVID shots

COVID vaccinations are likely to become an annual shot in the US. The US Food and Drug Administration on Monday have proposed to make COVID jabs like an annual flu shot. This, reports say, is a simplified approach for future vaccination efforts and will help in a better vaccination coverage…

The Independent UK

New hope for Alzheimer’s sufferers as FDA gives fast-track approval to experimental drug

The study also showed that Leqembi carries a risk of brain swelling and bleeding

Asharq Al-Awsat

California Lab-grown Meat Start-up Gets First Green Light

A California-based lab-grown meat start-up received the first green light for such products from the US food safety agency on Wednesday, although the product still has more hurdles to clear before being sold to consumers. The US Food and Drug Administration said it carried out a "careful evaluation" of Upside…

The Independent UK

High levels of cancer-causing chemical detected in dry shampoo, study finds

Benzene is a chemical which can raise the risk of some cancers after long-term exposure

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Over-the-counter hearing aids offer a wide range of options – here are things to consider before buying

Following the U.S. Food and Drug Administration’s ruling in August 2022, nonprescription over-the-counter hearing aids went on sale at pharmacies, supermarkets and consumer electronic stores on Oct. 17, 2022. These devices are intended only for people with perceived mild to moderate hearing loss.

StockNews.com

3 Stocks That Are Great for Passive Income Investors

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

Salon

Why is corn syrup in infant formulas?

Nearly half of US infant formula contain corn sugars. Mounting evidence suggests it may not be the best for babies

The Conversation

Ebola: what are the symptoms, how does it spread and where did it come from?

Uganda health authorities have declared an outbreak of Ebola disease. Ebola outbreaks emerge periodically in several African countries, most notably in the Democratic Republic of Congo (DRC). Public health expert Yap Boum, who has been involved in managing Ebola outbreaks in the past, answers some key questions about Ebola’s history,…

Tribune News Service

This company is bioengineering pig kidneys and livers for possible transplant into humans

In an Minnesota lab, clear containers hold pig kidneys and livers that scientists hope will someday be transplantable in humans.

StockNews.com

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

Benzinga

Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity of its investigational pentavalent meningococcal vaccine (MenABCWY) in healthy individuals 10 through 25 years of age. The trial met all primary and secondary endpoints. Pfizer shares traded in a range of $45.7…

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.